Article may be outdated

This article is 50 days old. Some details may have changed since publication.

biotechniques.com·3 min read·medium

AI Designs 16 New E. Coli-Targeting Bacteriophages

B
Beatrice Bowlby
AI Designs 16 New E. Coli-Targeting Bacteriophages
✦AI Summary

Stanford University researchers have utilized generative AI models to design 16 novel bacteriophages capable of targeting and destroying E. coli bacteria. This breakthrough represents the first time whole-genome design has been successfully achieved using language models trained on biological data.

Why it matters

This development could revolutionize medicine by providing a new, AI-driven method to combat antibiotic-resistant bacterial infections.

✦Dive DeeperCreate a free account to unlock

In a world-first, scientists have used genome language models to generate new viruses that selectively target bacteria, raising hopes for new medicines.

For the first time ever, Stanford University (CA, USA) researchers have designed hundreds of complete bacteriophage genomes using generative AI models. After testing the effectiveness of these phages against Escherichia coli , the team reports 16 novel viruses with potent bacteria-killing capabilities, potentially ushering in a new era of AI-guided therapeutic design.

Using AI to create complex biological systems has the potential to transform biotechnology. For example, genome language models, trained not on text but instead on millions of genomes from all domains of life, can learn evolutionary patterns that shape DNA in nature and use this to generate entirely new sequences. While progress has been made at the scale of individual genes and gene circuits, whole-genome design has thus far eluded scientists.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
sciencehealthai
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in